MBRX Moleculin Biotech, Inc.

0.93
+0  (6%)
Previous Close 0.88
Open 0.89
Price To book 0.71
Market Cap 15.97M
Shares 17,176,000
Volume 399,791
Short Ratio 0.78
Av. Daily Volume 941,887

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 1/2 data due 2018.
Annamycin
Acute myeloid leukemia (AML) - cancer